Ally Bridge Group »

Palisade Bio shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 1.2M 2.09

More positions owned by Ally Bridge Group

Definium Therapeutics Com Shs Call Option (DFTX)
Abivax Sa Sponsored Ads Call Option (ABVX)
Minerva Neurosciences Com New (NERV)
Promis Neurosciences Com Shs (PMN)
First Tracks Biotherapeutics Ord Shs (TRAX)
Axsome Therapeutics (AXSM)
Assembly Biosciences Com New (ASMB)
Aadi Bioscience (WHWK)
Edgewise Therapeutics (EWTX)
Eliem Therapeutics (CLYM)
Kura Oncology (KURA)
Cytomx Therapeutics (CTMX)
Avalo Therapeutics Sponsored Ads (AVTX)
Palisade Bio (PALI)
Solid Biosciences (SLDB)

View all positions for Ally Bridge Group

Top funds holding Palisade Bio

Soleus Capital Management
Ameriprise Financial
Jupiter Topco
Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Commodore Capital
RA Capital Management
Franklin Resources
Point72 Asset Management
Eversept Partners
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Geode Capital Management

View all funds holding Palisade Bio